Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Large Insider Purchases

Institutional-Scale SEC Form 4 Buy Signals

The Signal of $1M+ Conviction

When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.

Filing Date Trade Date Ticker Company Name Reporting Person Relationship Industry Type Price Qty Total, $ Owned After Change, %
2014-03-12 02:28 2014-03-07 OVAS Tempest Therapeutics, Inc. Longwood Fund, L.P. 10% owner Pharmaceutical Preparations BUY $10.00 100,000 $1,000,000 3,820,571 +2.7%
2014-03-12 04:35 2014-03-11 ODP ODP Corp Smith Jeffrey C Director, 10% owner Retail-Miscellaneous Shopping Goods Stores BUY $4.59 711,500 $3,264,220 28,872,697 +2.5%
2014-03-12 04:32 2014-03-07 ODP ODP Corp Smith Jeffrey C Director, 10% owner Retail-Miscellaneous Shopping Goods Stores BUY $4.59 2,162,413 $9,936,071 28,300,011 +8.3%
2014-03-12 02:28 2014-03-07 OVAS Tempest Therapeutics, Inc. Westphal Christoph H Director, 10% owner Pharmaceutical Preparations BUY $10.00 100,000 $1,000,000 3,820,571 +2.7%
2014-03-12 02:28 2014-03-07 OVAS Tempest Therapeutics, Inc. ALDRICH RICHARD Director, 10% owner Pharmaceutical Preparations BUY $10.00 100,000 $1,000,000 3,820,571 +2.7%
2014-03-11 23:44 2014-03-07 CIGW N/A Camellia Partners, LLC 10% owner Other BUY $100.00 30,000 $3,000,000 453,331 +7.1%
2014-03-11 18:07 2011-05-04 FDNH N/A OLIVER ROY T JR 10% owner Other BUY $0.46 19,694,433 $9,138,217 20,158,579 +4,243.2%
2014-03-11 00:21 2014-03-06 LOV N/A 402 CAPITAL LLC 10% owner Other BUY $4.58 259,383 $1,187,326 1,617,566 +19.1%
2014-03-11 04:52 2014-03-07 REGN REGENERON PHARMACEUTICALS, INC. Sanofi 10% owner Pharmaceutical Preparations BUY $332.51 241,818 $80,405,742 17,393,309 +1.4%
2014-03-11 04:51 2014-03-06 REGN REGENERON PHARMACEUTICALS, INC. Sanofi 10% owner Pharmaceutical Preparations BUY $328.72 150,277 $49,399,206 17,151,491 +0.9%
2014-03-07 18:57 2013-10-21 MCP N/A Molibdenos Y Metales S.A. 10% owner Other BUY $5.00 14,650,000 $73,191,400 46,700,700 +45.7%
2014-03-08 01:53 2014-03-06 GEVA N/A BAKER FELIX Director, 10% owner Other BUY $105.75 375,000 $39,656,250 211,614 +100.0%
2014-03-08 01:54 2014-03-06 GEVA N/A BAKER JULIAN Director, 10% owner Other BUY $105.75 375,000 $39,656,250 211,614 +100.0%
2014-03-08 01:27 2014-03-05 ACAD Acadia Pharmaceuticals Inc. BAKER BROS. ADVISORS LP Director, 10% owner Pharmaceutical Preparations BUY $28.50 526,316 $15,000,006 452,540 +100.0%
2014-03-07 01:02 2014-02-26 SVVC Firsthand Technology Value Fund, Inc. Bulldog Investors General Partnership 10% owner Other BUY $23.39 55,751 $1,304,289 1,037,343 +5.7%
2014-03-06 21:21 2014-02-26 SVVC Firsthand Technology Value Fund, Inc. Bulldog Investors, LLC 10% owner Other BUY $23.39 55,751 $1,304,289 1,054,163 +5.6%
2014-03-06 03:34 2014-03-05 ICUI ICU MEDICAL INC/DE Jain Vivek Director, Officer - Chairman and CEO Surgical & Medical Instruments & Apparatus BUY $58.75 30,000 $1,762,500 30,000 +100.0%
2014-03-06 05:16 2014-03-03 SLRC SLR Investment Corp. SPOHLER BRUCE J Director, Officer - COO and Director Other BUY $22.27 78,989 $1,759,433 2,134,638 +3.8%
2014-03-06 05:22 2014-03-03 SLRC SLR Investment Corp. GROSS MICHAEL S Director, Officer - See Remarks Other BUY $22.27 78,989 $1,759,433 2,134,638 +3.8%
2014-03-06 04:36 2014-03-03 REGN REGENERON PHARMACEUTICALS, INC. Sanofi 10% owner Pharmaceutical Preparations BUY $338.12 251,594 $85,070,121 17,001,214 +1.5%
2014-03-06 01:00 2014-03-04 IESC IES Holdings, Inc. GENDELL JEFFREY L ET AL 10% owner Electrical Work BUY $5.20 405,800 $2,110,160 10,787,040 +3.9%
2014-03-05 01:01 2014-02-28 TTS TILE SHOP HOLDINGS, INC. KAMIN PETER H Director Retail-Home Furniture, Furnishings & Equipment Stores BUY $15.56 95,600 $1,487,221 120,023 +391.4%
2014-03-05 00:11 2014-03-03 WES N/A ANADARKO PETROLEUM CORP 10% owner Other BUY $60.78 308,490 $18,750,022 50,053,824 +0.6%
2014-03-05 04:57 2014-02-28 XON PRECIGEN, INC. Frost Gregory Ian Officer - SVP--Health Sector Pharmaceutical Preparations BUY $25.95 100,000 $2,594,850 100,000 +100.0%
2014-03-04 16:00 2014-03-03 GE GENERAL ELECTRIC CO IMMELT JEFFREY R Director, Officer - Chairman and CEO Electronic & Other Electrical Equipment (No Computer Equip) BUY $25.19 104,900 $2,642,431 1,962,577 +5.6%
2014-03-04 17:06 2014-02-28 UIHC American Coastal Insurance Corp. POITEVINT ALEC II Director Fire, Marine & Casualty Insurance BUY $12.50 80,000 $1,000,008 404,297 +24.7%
2014-03-05 01:58 2013-08-14 WPT N/A NOVELLY PAUL A Director, Officer - SEE REMARKS Other BUY $20.00 300,000 $6,000,000 605,000 +98.4%
2014-03-05 00:49 2014-02-28 WSH WILLIS TOWERS WATSON PLC UBBEN JEFFREY W Director, 10% owner, Other Insurance Agents, Brokers & Service BUY $40.97 207,900 $8,518,474 18,422,600 +1.1%
2014-03-04 20:07 2014-03-03 KCG N/A JEFFERIES LLC 10% owner Other BUY $11.00 6,000,000 $66,000,000 22,467,774 +36.4%
2014-03-04 00:58 2014-02-28 AGCO AGCO Corporation SRINIVASAN MALLIKA Director Farm Machinery & Equipment BUY $51.86 60,729 $3,149,406 2,087,009 +3.0%
2014-03-04 00:54 2014-02-27 FSFR N/A TANNENBAUM LEONARD M Director, Officer - CEO Other BUY $14.15 74,071 $1,048,179 291,382 +34.1%
2014-02-28 21:39 2014-02-27 AGCO AGCO Corporation SRINIVASAN MALLIKA Director Farm Machinery & Equipment BUY $51.60 347,959 $17,954,684 2,026,280 +20.7%
2014-03-01 00:51 2014-02-26 HLF HERBALIFE LTD. ICAHN CARL C 10% owner Wholesale-Drugs, Proprietaries & Druggists' Sundries BUY $66.40 33,515 $2,225,396 17,000,000 +0.2%
2014-02-27 22:35 2014-02-11 UPNT N/A Lewis Gary C. Officer - PRESIDENT Other BUY $2,001.01 402,000 $804,404,010 202,000 +100.0%
2014-02-28 00:45 2014-02-25 BTX Lineage Cell Therapeutics, Inc. BROADWOOD PARTNERS LP Director, 10% owner Biological Products, (No Diagnostic Substances) BUY $3.74 500,000 $1,870,000 9,822,262 +5.4%
2014-02-28 04:43 2014-02-25 TWI TITAN INTERNATIONAL INC RACHESKY MARK H MD 10% owner Steel Works, Blast Furnaces & Rolling Mills (Coke Ovens) BUY $17.63 327,100 $5,765,138 5,490,748 +6.3%
2014-02-27 23:33 2014-02-25 CYTK CYTOKINETICS INC Eastern Capital LTD 10% owner Pharmaceutical Preparations BUY $8.00 500,000 $4,000,000 2,883,845 +21.0%
2014-02-27 03:51 2014-02-24 DVA DAVITA INC. WESCHLER, R. TED Other Services-Misc Health & Allied Services, NEC BUY $66.97 1,159,858 $77,679,402 37,621,152 +3.2%
2014-02-27 03:48 2014-02-24 DVA DAVITA INC. BERKSHIRE HATHAWAY INC 10% owner Services-Misc Health & Allied Services, NEC BUY $66.97 1,159,858 $77,679,402 37,621,152 +3.2%
2014-02-22 01:46 2014-02-20 CNCE N/A Freund John Gordon Director, 10% owner Other BUY $14.00 150,000 $2,100,000 1,208,920 +14.2%
2014-02-21 22:02 2014-02-19 CNCE N/A QVT Associates GP LLC 10% owner Other BUY $14.00 300,000 $4,200,000 559,999 +115.4%
2014-02-22 01:46 2014-02-20 CNCE N/A Skyline Venture Partners Qualified Purchaser Fund IV L P 10% owner Other BUY $14.00 150,000 $2,100,000 1,208,920 +14.2%
2014-02-21 23:18 2014-02-19 CNCE N/A Three Arch Management IV, L.L.C. Director, 10% owner Other BUY $14.00 103,500 $1,449,000 801,726 +14.8%
2014-02-21 23:18 2014-02-19 CNCE N/A THREE ARCH MANAGEMENT III LLC Director, 10% owner Other BUY $14.00 103,500 $1,449,000 777,620 +15.4%
2014-02-21 17:17 2014-02-20 KMI KINDER MORGAN, INC. KINDER RICHARD D Director, Officer, 10% owner - Chairman and CEO Natural Gas Transmission BUY $32.97 100,000 $3,297,280 231,688,110 +0.0%
2014-02-21 23:14 2014-02-19 CNCE N/A BROOKSIDE CAPITAL MANAGEMENT LLC 10% owner Other BUY $14.00 350,000 $4,900,000 1,497,833 +30.5%
2014-02-21 02:27 2014-02-19 ARP N/A COOPERMAN LEON G 10% owner Other BUY $20.80 60,000 $1,248,000 75,000 +400.0%
2014-02-20 23:01 2014-02-18 FLXN N/A Versant Venture Capital III, L.P. 10% owner Other BUY $13.00 307,692 $3,999,996 3,206,807 +10.6%
2014-02-20 23:00 2014-02-18 FLXN N/A Tordjman Rafael Director, 10% owner Other BUY $13.00 230,769 $2,999,997 2,105,491 +12.3%
2014-02-20 22:59 2014-02-18 FLXN N/A Sofinnova Partners SAS 10% owner Other BUY $13.00 230,769 $2,999,997 2,105,491 +12.3%
SHOW ENTRIES

Institutional Conviction in Form 4

Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.

Filtering the Market Noise

Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.